Mohammed Al Rubaei: Where Do I Start When Evaluating a Patient With Suspected Hemolysis?
Mohammed Al Rubaei, Internal Medicine Specialist at Sheikh Shakhbout Medical City – SSMC, shared on LinkedIn:
”Not every anemia is due to blood loss or decreased production.
Sometimes the problem is destruction.
Missing hemolytic anemia can delay life-saving treatment and expose patients to devastating complications such as acute kidney injury, thrombosis, organ failure, and even death.
Over the years, I found that many trainees struggle with one question:
‘Where do I start when evaluating a patient with suspected hemolysis?’
To simplify this, I developed a practical bedside approach that focuses on four key steps:
- Confirm hemolysis
- Identify the mechanism
- Determine the underlying cause
- Assess severity and urgency
Think hemolysis when anemia is accompanied by:
- Reticulocytosis
- Elevated LDH
- Elevated indirect bilirubin
- Low haptoglobin
- Abnormal peripheral smear findings
Never overlook critical diagnoses such as:
- Autoimmune hemolytic anemia (AIHA)
- TTP/HUS
- G6PD-related hemolysis
- Drug-induced hemolysis
- Mechanical valve hemolysis
- Severe infections including malaria
Red flags requiring urgent action:
- Hemodynamic instability
- Neurological symptoms
- Acute kidney injury
- Chest pain or myocardial ischemia
- Rapid hemoglobin decline
A well-performed history, peripheral smear, and DAT (Coombs test) often provide the biggest diagnostic clues.
This infographic focuses on the initial evaluation and early diagnostic approach to hemolytic anemia, particularly in acute care settings.
It represents the first step of a larger project.
Future versions will explore detailed diagnostic algorithms and cause-specific workups to help clinicians progress from recognizing hemolysis to identifying the underlying etiology and guiding definitive management.
I welcome feedback, suggestions, and shared experiences from colleagues.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026